comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-29 19:58:58 - browse：9558

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

WSS

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Will General Catalyst be the first of many hospital takeovers?

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

For Cytokinetics, FDA rejection of heart drug would help, not hinder

focus

comprehensive

Sponsor introduction

Featured speakers

Sponsored By

focus

At least 13 dead in Texas as scorching temps continue

Emergent cuts jobs, executive role in business shake

At least 13 dead in Texas as scorching temps continue

Methadone doses haven’t kept up in the age of fentanyl

The cancer drug shortage isn’t new — and neither are the solutions

UCSF medical school apologizes for unethical prisoner experiments

Heart attack and stroke risk calculators need revising

FDA panel issues narrow recommendation for Covid vaccine booster doses

Malaria cases in Florida and Texas: Here’s what you need to know

FDA panel issues narrow recommendation for Covid vaccine booster doses

focus

Naloxone nonprofit donates 200,000 doses after FDA approval

White House calls on federal agencies to crack down on AI abuses

Emergent cuts jobs, executive role in business shake

A biotech analyst on neuroscience, placebo effect, not over

Victims of gun violence feel impacts long after bullet wound

Wegovy’s successful heart trial raises vital question about weight loss

hotspot

Wikipedia

explore

hotspot